Medicine and Dentistry

1. Prostate Cancer 100%
2. Patient 80%
3. Man 78%
4. Therapeutic Procedure 66%
5. Follow up 49%
6. Neoplasm 40%
7. Malignant Neoplasm 38%
8. Hazard Ratio 27%
9. Biopsy Technique 25%
10. Cancer Research 24%
11. Magnetic Resonance Imaging 21%
12. Biological Marker 18%
13. Analysis 18%
14. Breast Tissue 17%
15. Diagnosis 15%
16. Surgical Margin 14%
17. Quadrantectomy 14%
18. Marker 14%
19. Cohort Analysis 13%
20. Risk Stratification 12%
21. Esophageal Cancer 12%
22. Breast Cancer 12%
23. COVID-19 10%
24. Health 10%
25. Glucose 10%
26. Neoadjuvant Chemotherapy 10%
27. Disease Burden 10%
28. Meta-Analysis 10%
29. Ovarian Cancer 10%
30. Esophageal Adenocarcinoma 10%
31. Low and Middle Income Countries 10%
32. Endoscopic Therapy 10%
33. Mental Health 10%
34. Esophagectomy 10%
35. Glycon 10%
36. Positron Emission Tomography-Computed Tomography 10%
37. Longevity 10%
38. B Lymphocyte 10%
39. Triple Negative Breast Cancer 10%
40. Prostate Biopsy 10%
41. Biological Activity 10%
42. Post-COVID-19 10%
43. Consensus 10%
44. Allele 10%
45. Hospital 9%
46. Screening 8%
47. Mortality 8%
48. Disease 7%
49. Cancer Risk 7%
50. Ex Vivo 7%